HIGHLIGHTS
- who: Lionel Lian Aun In and Michelle Yee Mun Teo from the University, China have published the article: Endolysins against Streptococci as an antibiotic alternative, in the Journal: (JOURNAL)
SUMMARY
No clinical trials involving endolysins targeting Streptococcus spp. have been conducted due to the lack of in_vivo studies (Abdelkader et_al, 2019; Abdelrahman et_al, 2021). The release of non-metabolized antibiotics or residues into the environment through feces can also accelerate the emergence of multidrug resistance (MDR) and AMR bacterial infections in society (Aslam et_al, 2018; AlvesBarroco et_al, 2020). Streptococcus spp. are Gram-positive . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.